NPPB and tricuspid valve insufficiency: After three months of treatment, the NT-proBNP levels, RA left and right diameters, RA upper and lower diameters, RV anterior and posterior diameters, inferior vena cava diameter, peak velocity of tricuspid regurgitation and PG, sPAP, WHO-FC, and risk stratification in both groups decreased compared to those before treatment.